AU1643776A - Anti-inflammatory compositions - Google Patents

Anti-inflammatory compositions

Info

Publication number
AU1643776A
AU1643776A AU16437/76A AU1643776A AU1643776A AU 1643776 A AU1643776 A AU 1643776A AU 16437/76 A AU16437/76 A AU 16437/76A AU 1643776 A AU1643776 A AU 1643776A AU 1643776 A AU1643776 A AU 1643776A
Authority
AU
Australia
Prior art keywords
inflammatory compositions
inflammatory
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU16437/76A
Other languages
English (en)
Inventor
Robert Bruce Clark
Sergio Henrique Ferreira
Nariman Bomanshaw Mehta
Peter Brian Thorogood
Ralph Vinegar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU1643776A publication Critical patent/AU1643776A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU16437/76A 1975-07-31 1976-07-30 Anti-inflammatory compositions Expired AU1643776A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200475 1975-07-31
GB3200575 1975-07-31
GB2718476 1976-06-30

Publications (1)

Publication Number Publication Date
AU1643776A true AU1643776A (en) 1978-02-02

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16437/76A Expired AU1643776A (en) 1975-07-31 1976-07-30 Anti-inflammatory compositions

Country Status (10)

Country Link
JP (1) JPS5218831A (enEXAMPLES)
AU (1) AU1643776A (enEXAMPLES)
DE (1) DE2634409A1 (enEXAMPLES)
DK (1) DK345676A (enEXAMPLES)
FR (1) FR2319346A1 (enEXAMPLES)
IL (1) IL50174A0 (enEXAMPLES)
LU (1) LU75513A1 (enEXAMPLES)
NL (1) NL7608503A (enEXAMPLES)
NZ (1) NZ181635A (enEXAMPLES)
SE (1) SE7608611L (enEXAMPLES)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614143B2 (en) * 1988-06-02 1991-08-22 Bristol-Myers Squibb Company Method for enhancing transdermal penetration and compositions useful therein

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
IT1194677B (it) * 1980-08-05 1988-09-22 Italfarmaco Spa Composizione farmaceutica ad attivita' antiflogistica,antipiretica e antalgica
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU614143B2 (en) * 1988-06-02 1991-08-22 Bristol-Myers Squibb Company Method for enhancing transdermal penetration and compositions useful therein

Also Published As

Publication number Publication date
DK345676A (da) 1977-02-01
DE2634409A1 (de) 1977-02-17
IL50174A0 (en) 1976-09-30
NZ181635A (en) 1978-09-25
FR2319346B1 (enEXAMPLES) 1979-05-25
NL7608503A (nl) 1977-02-02
JPS5218831A (en) 1977-02-12
SE7608611L (sv) 1977-02-01
LU75513A1 (enEXAMPLES) 1977-04-15
FR2319346A1 (fr) 1977-02-25

Similar Documents

Publication Publication Date Title
JPS51150560A (en) Filmmforming compositions
JPS51150561A (en) Filmmforming compositions
EG12289A (en) Microbicial composition
GB1550139A (en) Anti-inflammatory compositions for oral application
GB1538554A (en) Hydrocurable compositions
PH11857A (en) Novel anti-inflammatory agents
CY1153A (en) Pharmaceutical compositions
JPS51112508A (en) Composition
GB1548675A (en) Odiurant compositions
GB1549326A (en) Sunprotective compositions
AU1643776A (en) Anti-inflammatory compositions
PH11893A (en) Match-head compositions
GB1543907A (en) Steroid compositions
JPS5232924A (en) Soluvent compositions
IL51483A0 (en) Anti-inflammatory compositions comprising 2-cyclopropanecarboxamido-5-halothiazoles
AU1100676A (en) Anti-histomonal composition
ZA767215B (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
JPS5271552A (en) Compositions
GB1552416A (en) Pharmaceutical compositions
ZA761012B (en) Pharmaceutical compositions
PT64948B (en) Compositions
ZA764808B (en) Novel anti-inflammatory agents
JPS51116848A (en) Moistrueeprevnting compositions
ZA763806B (en) Pharmaceutical compositions